Accenture plc (CSA) Share Price

SNOW
Snowflake price target raised to $203 from $190 at Barclays
Barclays raised the firm's price target on Snowflake to $203 from $190 and keeps an Overweight rating on the shares. The company reported a "healthy" Q4 and delivered fiscal 2026 sales guidance ahead of Street expectat

Starting to panic? Pity, really.

Several Dairy Queen groups are closing/filing bankruptcy. Don't worry. Everything is fine. Idiots.

Hope you bought 
$RILY at 3 or 4 
🤭🚀💵

B. Riley Financial Announces $160 Million Debt Financing Provided by Oaktree

NVDA
Nvidia price target raised to $162 from $152 at Morgan Stanley
Morgan Stanley raised the firm's price target on Nvidia to $162 from $152 and keeps an Overweight rating on the shares. Q4 revenues were slightly better than the firm previewed, with gross margins slightly worse, th

Rnaz will bounce higher today. Go. Rnaz

Well....it remains safe...not all endpoints (especially the failed primary endpoints) or the placebo arm point to effective for AD...and definitely not effective for Rett. Trials for PD took forever to get going and still aren't started...What are they hiding?

Doesn't matter the science. This is a business. Gotta follow the Benjamins. That's all that matters

2.89 is a gift i added. 800. Shares.  Go. RNAZ

hyperopia, thx much for the factual response. Your patience, technical understanding and writing are very helpful to all here.
Given the timing now vs when NWBO published their 2/24 PR, do you think it is too optimistic to think the re-inspection may have been due to FW qualification?

Fife is working with CYDY in a positive manner and has eased off the pedal considerably.

Nvidia ( $NVDA):
• Q4 adj. EPS $0.89 (est. $0.84)
• revs $39.33B (est. $38.05B)
• Data center revs $35.6B (+93%)
• Auto $570M (+103%)
• Gaming $2.5B (-11%)
• Q1 revs $43B ±2% (est. $41.78B).

🔸 Amazon ( $AMZN): Debuted Ocelot, its firs

good morning

🔮🔮🔮🔮🔮

There is no IsoPet data. Cherry picked dogs, cats and some large animals with little to no image monitoring post treatment are anecdotes, not data. We already know FDA needs controlled data (like the JHU rabbit work) to consider Radiogel for human trials. IsoPet is useless in that regard. Moreov

That would probably be a year or so.  Idk 
I beleive it will take at least that to get in position .

$NIXX 📰Big News Out Yesterday: Nixxy Announces $10 Million Share Repurchase Program
https://finance.yahoo.com/news/nixxy-announces-10-million-share-134500327.html

Midnight Sun's COO, Kevin Bonel, stated: "We are incredibly pleased with the results and brand-new targets generated by the Partial Ionic Leach sampling and IP survey. Taking the coincidence of a well-defined copper anomaly, in the 'right geology' with an underlying high chargeability, low resistivi

ICCT......HWH......FBGL.......VMAR........MULN..................https://stockcharts.com/h-sc/ui?s=MULN&p=D&yr=0&mn=2&dy=12&id=p84071410134

📰Big News Out Yesterday: Nixxy Announces $10 Million Share Repurchase Program
https://finance.yahoo.com/news/nixxy-announces-10-million-share-134500327.html

$NIXX

Careful planning is all non-sense; FHFA knows what to do.

Mike Tyson famously said, "Everybody has a plan until they get punched in the mouth," before his fight with Evander Holyfield, when he was asked if he was worried about his opponent's plans.

I am sure some of tha

Yes, great news marcis

RR......KULR.......PRCH.........VUZI..............................https://stockcharts.com/h-sc/ui?s=RR&p=D&yr=0&mn=2&dy=12&id=p84071410134

Zion employees are not allowed to sell shares, at least it was that way a very long time now...years. could have changed, but I doubt it.